Fluconazole therapy in Candida albicans spondylodiscitis

Scand J Infect Dis. 1998;30(5):527-30. doi: 10.1080/00365549850161601.

Abstract

A case of Candida albicans spondylodiscitis in a 20-year-old female liver transplant recipient is reported. The patient was successfully treated with sequential therapy with liposomal amphotericin B and fluconazole. A review of the literature showed 10 cases of Candida albicans spondylodiscitis successfully treated either with fluconazole alone or a sequential therapy with amphotericin B and fluconazole. If long-term amphotericin B therapy is not feasible, a prolonged course of fluconazole in a daily dose of 200-400 mg may be considered as an alternative.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use*
  • Candida albicans / isolation & purification
  • Candidiasis / diagnosis
  • Candidiasis / drug therapy*
  • Discitis / drug therapy
  • Discitis / microbiology*
  • Drug Therapy, Combination
  • Female
  • Fluconazole / therapeutic use*
  • Humans
  • Liver Transplantation

Substances

  • Antifungal Agents
  • Amphotericin B
  • Fluconazole